Sensei Biotherapeutics News - SNSE

Company Name	Stock Ticker Symbol	Market	Type
Sensei Biotherapeutics Inc	SNSE	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.0199	1.99%	1.02	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
1.04	1.00	1.04	1.02	1.0001

more quote information »

Recent News

Date	Time	Source	Heading
3/05/2024	16:44	EDGAR2	Form 8-K - Current report
2/28/2024	07:31	EDGAR2	Form 8-K - Current report
2/16/2024	18:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/16/2024	18:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/16/2024	18:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/08/2024	16:31	EDGAR2	Form 8-K - Current report
1/04/2024	08:14	EDGAR2	Form 8-K - Current report
11/07/2023	16:40	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	07:35	EDGAR2	Form 8-K - Current report
11/07/2023	07:30	GLOBE	Sensei Biotherapeutics Reports Third Quarter 2023 Financial..
11/06/2023	06:07	EDGAR2	Form 8-K - Current report
11/03/2023	16:11	EDGAR2	Form 8-K - Current report
11/03/2023	16:05	GLOBE	Sensei Biotherapeutics Reports Favorable Clinical Data for..
11/02/2023	16:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/02/2023	16:50	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/01/2023	07:30	GLOBE	Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as..
10/25/2023	09:05	GLOBE	Sensei Biotherapeutics to Present Initial Clinical Data from..
10/23/2023	07:30	GLOBE	Sensei Biotherapeutics Presents Trial-in-Progress Poster for..
10/20/2023	17:01	EDGAR2	Form 8-K - Current report
9/27/2023	07:30	GLOBE	Sensei Biotherapeutics Announces Initiation of Combination..
9/21/2023	07:30	GLOBE	Sensei Biotherapeutics Presents New Preclinical Data..
9/13/2023	08:43	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/13/2023	07:30	GLOBE	Sensei Biotherapeutics to Present New Preclinical Data..
9/11/2023	17:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/11/2023	17:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/11/2023	17:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/11/2023	17:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/30/2023	07:30	GLOBE	Sensei Biotherapeutics to Participate in Upcoming Investor..
8/17/2023	17:15	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/03/2023	16:32	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/2023	08:45	EDGAR2	Form 8-K - Current report
8/03/2023	07:30	GLOBE	Sensei Biotherapeutics Reports Second Quarter 2023 Financial..
8/02/2023	17:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/02/2023	07:30	GLOBE	Sensei Biotherapeutics to Participate in Canaccord Genuity’s..
7/12/2023	16:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/12/2023	16:48	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/12/2023	16:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/12/2023	16:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/12/2023	16:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/10/2023	16:31	EDGAR2	Form 8-K - Current report
6/01/2023	07:30	GLOBE	Sensei Biotherapeutics Announces First Patient Dosed in..
5/09/2023	07:30	GLOBE	Sensei Biotherapeutics Reports First Quarter 2023 Financial..